The cap3B gene, which is involved in the formation of the capsule of Streptococcus pneumoniae type 3, encodes a 49-kD protein that has been identified as a polysaccharide synthase. Escherichia coli cells harboring the recombinant plasmid pTBP3 (cap3B) produced pneumococcal type 3 polysaccharide, as demonstrated by immunological tests. Biochemical and cell fractionation analyses revealed that this polysaccharide had a high molecular mass and was localized in substantial amounts in the periplasmic space orE. coli. Unencapsulated ($2-), laboratory pneumococcal strains synthesized type 3 polysaccharide by transformation with plasmid pLSE3B harboring cap3B. In addition, encapsulated pneumococci of types 1, 2, 5, or 8 transformed with pLSE3B can direct the synthesis ofpneumococcal type 3 polysaccharide, leading to the formation of strains that display binary type of capsule.
Summary
The cap3B gene, which is involved in the formation of the capsule of Streptococcus pneumoniae type 3, encodes a 49-kD protein that has been identified as a polysaccharide synthase. Escherichia coli cells harboring the recombinant plasmid pTBP3 (cap3B) produced pneumococcal type 3 polysaccharide, as demonstrated by immunological tests. Biochemical and cell fractionation analyses revealed that this polysaccharide had a high molecular mass and was localized in substantial amounts in the periplasmic space orE. coli. Unencapsulated ($2-), laboratory pneumococcal strains synthesized type 3 polysaccharide by transformation with plasmid pLSE3B harboring cap3B. In addition, encapsulated pneumococci of types 1, 2, 5, or 8 transformed with pLSE3B can direct the synthesis ofpneumococcal type 3 polysaccharide, leading to the formation of strains that display binary type of capsule. C apsular polysaccharide protects bacteria from phagocytosis by polymorphonuclear leukocytes, and the virulence of Streptococcus pneumoniae is determined by the size and the chemical composition of the capsule (1) . 90 different capsular types of S. pneumoniae have been described (2) and variations in capsular serotype by in vivo and in vitro experiments led to the identification of DNA as the "tramforming principle" (3, 4) . The importance of these types of genetic exchanges in nature has recently been suggested as a source of variation of the different pneumococcal strains to expand their capacity of colonizing the host organism (5) .
Type 3 pneumococci produce a capsule composed of cellobiuronic acid units connected in a [3(1-+3) linkage (6) . Cellobiuronic acid is a disaccharide consisting of D-glucuronic acid (GlcA) 1 [3(1-+4) linked to D-glucose (Glc). Recently, the genes implicated in the biosynthesis of type 3 capsular polysaccharide have been cloned and some of them have been partially characterized (7) (8) (9) (10) (11) (12) . At least three type 3-specific genes have been found, namely, cap3A, B, and C (also designated as cps3D, S and U, respectively). Genetic and biochemical analyses showed that Cap3A is a UDP-Glc dehydrogenase that converts UDP-Glc into UDP-GlcA (8, 12) , whereas cap3 C complements the galU defect of Escherichia coli and, therefore, codes for a UDP-Glc pyrophosphorylase (11) . On the other hand, sequence comparison suggested that cap3B might code for the type-specific polysaccharide synthase, although a precise settlement could not be reached ~Abbreviations used in this paper: Glc, glucose; GlcA, glucuronic acid;
at that moment. The genes cap3A, B, and C are transcribed together, and insertion-duplication mutagenesis revealed that cap3C is not essential for capsule formation (11) . Classical genetic studies ofpneumococcal capsular type 3 strains suggested that all but one of the spontaneous mutations that alter the formation of type 3 polysaccharide were located in cap3A (13) . Several cap3A point mutations have now been characterized, and some of them completely blocked the synthesis of type 3 polysaccharide (8, 10), whereas only a deletion affecting simultaneously cap3A and cap3B (13) or insertion mutations (10) affecting cap3B have been reported so far. Since polar effects are likely to occur as a consequence of plasrnid or transposon insertion, a definite conclusion on the role of Cap3B on capsular biosynthesis still awaited the isolation and characterization of cap3B point mutants.
In this communication, we report the isolation and characterization ofa cap3B mutant. We also show that Cap3B is a synthase that led to the synthesis of type 3 pneumococcal polysaccharide of high molecular mass in E. roll, and that was sufficient to produce binary capsulated strains when cloned into several S. pneumoniae encapsulated strains belonging to several serotypes.
Materials and Methods
Bacterial Strains, Plasmids and Growth Conditions. The type 3 S. pneumoniae strain 406 has been described elsewhere (7) . The pneumococcal strain M25, a type 1 encapsulated derivative of the laboratory strain M24 (7), was constructed by M. Mollerach in our laboratory by transformation with DNA from a type 1 clini-cal isolate of S. pneumoniae. Other pneumococcal strains were clinical isolates belonging to serotypes 2 (15783/94), 5 (8595/95), and 8 (6028), and were provided by A. Fenoll from the Spanish Reference Laboratory for Pneumococci (Instituto de Salud Carlos III, Majadahonda, Madrid). The unencapsulated $3-strain NP,.3-10 is a spontaneous nmtant of the pneumococcal strain NS3-1 (8), isolated as described elsewhere in detail (7) . Two nonencapsulated ($2-) mutants used in some experiments were the laboratory strains Mll and M31 (14) . These strains were late descendants of the strain R36A (4). S. pneumoniae strains were grown in liquid C+Y medium (7) or on reconstituted tryptose blood agar base plates (Difco Laboratories, Detroit, MI) supplemented with 5% (vol/vol) defibrinated sheep blood. Serotyping was carried out by the "Quellung" reaction with type-specific antisera purchased from the Staten Seruminstitut (Copenhagen, Denmark) (15) . The same antisera were used for other immunological techniques (see below). E. coli strains BL21(DE3) (16), C600 (17) , and DH10B (F' mcrA A(mrr hsdRMS-mcrBC) ~80dlacZA M15 AlacX74 deoR recAl araD139 A(ara-leu)7697 galU galK X-rpsL endA I nupG) (Life Technologies) were used as hosts for recombinant plasmids and grown in LB medimn (17) . Plasmids pLysS (16), pT7-7 (18), pLSE1 (19) , and pKEP,2, pKER22, and pKEP,23 (8) have been already described.
DNA Manipulation, Plasmid Construction, and Genetic Transformation. Preparation of plasmid DNA, digestion with restriction endonucleases, ligation reactions, and agarose gel electrophoresis followed standard procedures (17) . PCR amplification of cap3B was performed by using 2 U of Taq polymerase (Perkin-Elmer Cetus Corp., Norwalk, CT), 10 ng ofplasmid pKER2, 1 I~M of each synthetic oligonucleotide primer, 250 bLM of each dNTP, and 5 mM MgC12 in the buffer recommended by the manufacturers. Amplification was achieved with a cycle of 3 rain denaturation at 95~ 2 min annealing at 69~ and 5 rain polymerase extension at 72~ repeated 40 times with a final 6-rain extension at 72~ and slow cooling to 4~ with a Gene ATAQ controller (Pharmacia LKI~, Piscataway, NJ). The following synthetic oligonucleotides were used: PCAP3B (5'-CTATACACGCGATT-CATATGGCAGAG-3') and PCAP21 (5'-GTGTGCCCAGCC-CTGCAGC-3'); the underlined sequence indicates restriction site for NdeI. Transformation of competent cells of S. pneumoniae (19) and E. coli (17) have been described. Before addition of transforming DNA, clinical isolates of S. pneumoniae were incubated with a crude preparation of competence factor, as previously reported (20). Transformants of S. pneumoniae and E. coil obtained with plasnfids derived from pLSE1 were selected by plating with lincomycin (1 txg/ml), or erythromycin (500 I~g/ ml), respectively. When pT7-7 or its derivative pTBP3 (see below) were used as donor DNAs, E. coli BL21(DE3)pLysS transformants were scored on LB agar plates containing chloramphenicol (20 ~g/ml) and ampicillin (75 btg/ml). DNA sequencing was carried out with appropriate oligonucleotides with an Abi Prism 377 DNA Sequencer (Perkin-Elmer Cetus).
Characterization of Capsular Polysaccharide. Highly purified pneumococcal polysaccharides were prepared essentially as described elsewhere (15) . Briefly, exponentially growing cultures of S. pneumoniae in C+Y n~edium were lysed by the addition of 1% sodium deoxycholate (final concentration) and incubation at 37~ for 30 rain. When lytA mutants were used, cells were incubated with 5 p~g/ml of LytA pneumococcal autolysin (6 • 1() ~ U/mg) for 30 miu at 37~ before the addition of sodium deoxycholate. The lysate was acidified with acetic acid (0.5% final concentration) and heated to boiling point. After cooling, the mixture was neutralized with NaOH and deproteinized with chloroform/isoamyl alcohol (24:1). The polysaccharide was precipitated by adding 2 vol of cold absolute ethanol. After standing overnight at 4~ the precipitate was recovered by centrifugation (10,000 g for 30 rain), washed once with 96% ethanol, twice with diethyl ether, and dried at 65~ The polysaccharide was dissolved in distilled water and deproteinized again twice with phenol/chloroform/isoamyl alcohol (25:24:1) and once more with chloroform/isoamyl alcohol. Afterwards, the aqueous phase received sodium acetate (final concentration = 5%), and the polysaccharide was precipitated with half its volume of isopropanol. After standing overnight at 4~ the polysaccharide was washed as described above, dried, and dissolved in distilled water. For rapid, crude preparations of pneumococcal polysaccharides, 1.5 ml of late exponentially growing cultures of S. p~ieumoniae were treated as described above, except that the deproteinization step was excluded, and the polysaccharide was precipitated only once with absolute ethanol and dissolved in 100 I~1 of distilled water.
The uronic acid content of the purified type 3 polysaccharide was measured by the carbazole assay (21) with glucuronic acid as the standard. The mass of the polymers was determined by gel filtration (22) with Sepharose CL-4B (Pharmacia Biotech, Uppsala, Sweden). Double-diffusion experiments were performed on 0.7% agarose-coated microscope slides as previously described (23). To estimate the amount of type 3 polysaccharide present in a sample, 5 btl of serial dilutions of the extract and known amounts of purified polysaccharide were analyzed by immunodiffusion against 5 btl of the same batch of type 3 antiserum. In these experimental conditions, 0.25 ~g of type 3 polysaccharide is enough to give a tiny but still visible precipitation band after overnight incubation.
Miscellaneous Techniques. SDS-PAGE was carried out as described by Laemmli (24). After SDS-PAGE, proteins were blotted onto a polyvinylidene dittuoride membrane (Immobilon-pSQ; Millipore Corp., Bedford, MA), and stained briefly with amido black (Sigma Immunochemicals, St. Louis, MO). Subsequently, the desired band was cut and the NH2-terminal amino acid sequence was detemfined as described elsewhere (25). Preparation ofspheroplasts and fractionation of E. coli cells were carried out as previously described (26) .
Results

cap3B Is hwolved in Capsular Biosynthesis.
We reported previously the isolation of 12 spontaneous $3-strains that were characterized as cap3A nmtants on the basis of transformation to the smooth phenotype with the wild-type cap3A gene (8) . In a subsequent round of isolation of rough mutants, however, one of them (strain NP,3-10) was not transformed to the $3 + phenotype by the cap3A + allele, and was studied in detail. When the cap3B gene of the wild-type strain 406 was amplified by PCR and used to transform competent NR.3-10 cells, fully capsulated transformants were obtained (Fig. 1) . The mutation could be mapped more accurately by transformation experiments with different restriction fragnnents of cap3B. and the corresponding products were sequenced. In addition, the sequence previously reported for the wild-type gene (11) was fully confirmed by direct sequencing of the PCR-amplified cap3B gene of the 406 strain. These results taken together demonstrated that Cap3B directly participates in the synthesis of type 3 pneumococcal polysaccharide.
The frameshifting that originated in the strain NR3-10 should cause the synthesis of a truncated, and possibly inactive, Cap3B protein. Nevertheless, a closer inspection of NR3-10 revealed the presence of a small amount of type 3 capsular polysaccharide (~-,10% of that found in the wildtype strain; not shown). This finding might be explained as the result of the slippage of one nucleotide during translation of the mRNA of the mutant strain, as already described for several genes in other species (27) .
Cloning and Expression of cap3B in E. coli. Several groups
have experienced severe difficulties in cloning the functional pneumococcal genes in E. coli. In particular, expression of cap3B in E. coli was lethal to the host and, consequently, characterization of the enzyme could not be achieved (10) . To overcome this problem, we tried to clone cap3B under the control of the T7 promoter as shown in Fig. 2 . In short, a DNA fragment containing cap3B was amplified by PCR using plasmid pKER2 and the oligonucleotides PCAP3B and PCAP21 as primers. After digestion with NdeI (a target site engineered in PCAP3B) and PstI, the cap3B gene was ligated to pT7-7 previously digested with the same enzymes, introduced by transformation into E. coli DH10B, and the recombinant plasmid resistant clone and used to transform E. coli BL21(DE3) pLysS. The presence ofpLysS was an absolute requirement for successful transformation with pTBP3, since preliminary experiments using the E. coli strain BL21(DE3) did not yield any transformants (not shown). To clone cap3B into pLSE1, a plasmid able to replicate both in E. coli and S. pneumoniae (19) , the 2-kb PvulI/HindlII fragment of pKER2 was ligated to pLSE1 previously digested with E c o R V and HindlII (Fig. 2) . The ligation mixture was used to transform E. coli C600, and pLSE3B was selected by screening among the erythromycin-resistant transformants. It was expected that expression o f cap3B would be under the control of the tetracycline promoter of the vector plasmid, as it has been reported for other genes (28 and references therein).
For T7 expression, E. coli cells harboring pTBP3 were grown in LB medium up to an OD600 of 0.6 and induced with isopropyl-IB-D-thiogatactopyranoside (IPTG; 1 mM). A 49-kD protein, corresponding to the expected size of Cap3B (11), was observed after a 90-rain induction, as shown by SDS-PAGE of cellular crude extracts (Fig. 3 A) . This band was cut from the gel, and determination of the NH2-terminal amino acid sequence yielded Met-Tyr-ThrPhe-Ile-Leu, thus confirming the sequence deduced from the nucleotide analysis of the cap3B gene (11) . Control cells containing pT7-7 did not show any additional protein band over a 3-h time course experiment.
Synthesis and Analysis of the Pneumococcal Type 3 Polysaccharide in E. coli. Sonicated extracts prepared from both induced and uninduced cultures of E. coli BL21 (DE3)pLysS
harboring pTBP3 contained type 3 polysaccharide, as demonstrated by immunoprecipitation with a type-specific antiserum (Fig. 3 B) . The amount of type 3 polysaccharide found in uninduced E. coli cells was 10-25% of that of induced cultures. This result is in agreement with an incomplete repression of the T7 promoter in the host strain used here, as it has been reported previously (16) . O n the other hand, IPTG-induced E. coli cultures synthesized as much as 1-5% of the amount of type 3 polysaccharide synthesized by S. pneumoniae (between 10 and 50 ~g per 108 cells; our unpublished results). Uninduced E. coli cultures harboring pTBP3 were used to determine the subcellular localization of the pneumococcal polysaccharide. It was found that a substantial amount (~40%) of the type 3 polysaccharide was localized in the periplasmic space of E. coli, 40-50% was in the cytoplasm, and the rest were in the membrane fraction (not shown). This polysaccharide was further characterized by gel filtration chromatography, showing it to be highly polymerized as it eluted in the void volume of a Sepharose CL-4B column (not shown). These results indicated that Cap3B is actually the enzyme that synthesizes the type 3 pneumococcal polysaccharide.
Formation of Binary Cells of Pneumococcus by Transformation
with the cap3B Gene. Pneumococcal strains that produce simultaneously two distinct capsular polysaccharides have been described previously (see reference 29 for a review). These strains arise by transformation reactions between pneumococci-expressing capsules that contain hexuronic acids, such as those belonging to serotypes 1 and 3. When the plasmid pLSE3B was introduced by transformation into the $1 pneumococcal strain M25, all the lincomycin-resisrant transformants expressed both type 1 and type 3 capsular polysaccharides, as determined by the Quellung reaction (data not shown), as well as by immunodiffusion analysis of cell extracts with specific antisera (Fig. 4) . This result was not restricted to serotypes 1 and 3 because pneumococcal cells belonging to serotypes 2, 5, and 8, all of them producing capsules that contain glucuronic acid (30) , also gave rise to binary transformants when transformed with pLSE3B. Furthermore, strains Mll and M31, two $2-laboratory derivatives of the rough strain R36A, also synthesized type 3 capsule (but not type 2) when transformed with pLSE3B (Fig. 4) . In every case, the type 3 polysaccharide produced was of high Mr, as demonstrated by gel filtration (not shown).
Discussion
The molecular organization of the genes implicated in capsulation of S. pneumoniae is currently being studied. As in Gram-negative bacteria (31) , genes involved in the synthesis of the sugar precursors and the polymerization reactions appear to be specific for any given capsular type also in S. pneumoniae (7) (8) (9) (10) (11) (12) 32) . Type 3--specific genes are arranged as an operon, and the promoter is located just upstream of the first specific gene (cap3A) (11) . In type 19F, however, Guidolin and co-workers (32) suggested that upstream of the type-specific genes, the transcript included several open reading frames common to all pneumococci. Thus, it appears that diverse functional organizations of the capsular genes may exist in different pneumococcal serotypes.
Very few gene products thought to be implicated in capsule formation in Gram-positive bacteria have been identified biochemically so far. Among these, the S. pyogenes hasA codes for an enzyme that directs hyaluronic acid biosynthesis, the component of the capsule of this microorganism (33) (34) (35) . It has been shown that HasA is necessary and sufficient to synthesize hyaluronic acid both in Enterococcusfaecalis and in E. coli, provided that the host bacterium produces the corresponding sugar nucleotides (UDP-GlcA and UDP-N-acetyl glucosamine) (36) . This relationship appears also to be the case for the pneumococcal Cap3B synthase (Fig. 3 B) . In addition to the omnipresent UDPGlc, which plays a central role in the biosynthesis of most cellular polysaccharides, UDP-GlcA has been found both in E. coli (37) (38) (39) and in some S. pneumoniae serotypes (40) . Since type 1 capsule contains galacturonic acid, a specific epimerase reaction is required to convert UDP-GlcA to UDP-GalA (41) . Furthermore, since pTBP3 and pLSE3B contain exclusively the cap3B gene as an insert (Fig. 2) , it is clear that the Cap3B synthase has both UDP-Glc and UDP-GlcA glycosyltransferase activities and possibly synthesizes the type 3 polysaccharide in a processive manner by monomer addition. In S. pyogenes, Dougherty and van de Rijn (34) speculated that HasA synthase may catalyze transfer of only one of the two sugars, N-acetyl glucosamine, to the nascent hyaluronic acid chain. Nevertheless, DeAngelis and Weigel (35) concluded that HasA is a synthase that possesses both glycosyl transferase activities that are required to polymerize hyaluronic acid.
In E. coli and in other capsulated Gram-negative bacteria, the capsular polysaccharide determinants were shown to contain three phenotypically distinct regions associated with polysaccharide expression. Region 1 is necessary for the transport of mature, lipid-linked polysaccharide across the outer membrane and its assembly into a capsule. Region 2 is serotype specific and codes for the enzymes involved in synthesis and polymerization. Region 3 is responsible for the translocation of the polysaccharide across the cytoplasmic membrane (42) . The KpsMT proteins coded by genes located in region 3 and belonging to the family of ABC transporters (43) are capable of transporting a variety of acidic polysaccharides to the periplasm. Of particular interest is the finding reported here that ~50% of the pneumococcal type 3 polysaccharide synthesized in E. coli appears in the periplasmic space, although we can not determine whether the mechanism for this transport is the same as that for the homologous polysaccharide.
In Gram-positive bacteria, the mechanism ofpolysaccharide transport has not been characterized so far. In type 19F pneumococci, it has been suggested that some of the genes located upstream of the specific capsular cluster (namely, cps 19fA-D) might be responsible for the transport of the intracellularly synthesized capsular polysaccharide (32) . However, we have recently shown that the genes corresponding to those described by Guidolin et al. are not functional in pneumococci belonging to the type 3 serotype (11). The results reported here strongly suggest that another stillunknown mechanism may be responsible for the export of the capsular polysaccharide through the cytoplasmic membrane.
We have shown that the presence of the type 3 pneumococcal polysaccharide synthase is sufficient to direct the synthesis of a type 3 capsule in S. pneumoniae strains belonging to serotypes 1, 2, 5, and 8 (Fig. 4) . It can be assumed that the mechanism of polysaccharide transport of the recipient cell is used for the formation of a type 3 capsule in the binary transformants. Early experimental evidence showed that when an unencapsulated mutant of type 3 is transformed with DNA from a capsulated strain of type 1, a minority (2-5%) of the transformants were of the binary type, i.e., they reacted with both types 1 and 3 antisera and synthesized two distinct polysaccharides (44) . Transformation experiments with these stable binary strains suggested that a supernumerary gene cluster (i.e., type 1) had been inserted, presumably by homologous recombination, at a repeat element unlinked to the capsule locus (reviewed in 29). Recently, we have shown that copies of the DNA sequences located upstream of the cap3ABC operon are present in different locations in the genome (8) . In contrast with this situation, the transformants described here resuited from the expression of the plasmid-borne cap3B gene. In conclusion, provided that the corresponding sugar nucleotide precursors (UDP-Glc and UDP-GlcA) are present, cap3B appears to be the only gene required to direct type 3 polysaccharide biosynthesis in the pneumococcal strains or in E. coli.
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